Could the Kiss Hormone Aid in Fertility Treatments?

fertility options

Doctors in the UK are currently working on a more natural fertility option after the recent discovery that the kiss hormone could be a safer, more effective form of IVF treatment. It is estimated that one in six couple’s experiences fertility issues within the UK, causing significant social and mental health implications.

Conventional IVF treatment can prove successful for couple’s struggling with fertility, but it isn’t without its risks. The treatment is renowned for being a long and difficult process, but most worryingly, it can also lead to life-threatening complications. While the incidence of such complications is rare, the risk is always a worry for those seeking treatment. That’s why this new discovery is causing excitement and hope within the industry.

What is the kiss hormone and how does it aid fertility?

The Kisspeptin hormone is naturally occurring within the body and it’s used by the brain to trigger ovulation. Landmark studies carried out in 2003, also determined it plays a large role in puberty. Without the hormone, the studies showed humans and animals were unable to enter puberty. The hormone has also been shown to be extremely important in the reproduction system of both animals and humans.

In order to determine whether Kisspeptin could be an asset during fertility treatment, the Imperial College conducted clinical trials. A total of £1.5 million was provided by the National Institute for Health Research and the Medical Research Council to aid with the trial and the results have proven extremely promising.

Since the trials begun at the Imperial College, there have been 73 healthy babies delivered via Kisspeptin IVF treatment. There were 176 couples taking part in the trials and the live birth rate was recorded at 36%, an impressive 10% more than standard IVF treatment.

The Kisspeptin hormone replaces the Human Chronic Gonadotropin (HCG) used in conventional IVF. It has proven to be gentler on the body, and effective at releasing a larger number of eggs.

How soon will the treatment be available?

Although the results of the study are promising, Kisspeptin based IVF treatment isn’t likely to be introduced for quite some time. Now the doctors have discovered its effectiveness, they’re working on developing an adapted form of Kisspeptin alongside a private drug company.

They are also looking for funding for an additional large-scale study which will highlight the effectiveness and safety of the treatment.

What fertility options do couples have right now?

The Kisspeptin IVF treatment may not be available for years, but there are treatment options currently available for couples which have proven to be effective. While conventional IVF can produce significant risks, complications are rare, and it remains one of the most effective treatments on offer.

Other fertility options available include ovulation induction, IUI, egg donation and ICSI. The treatment recommended will depend upon the results of an extensive fertility assessment. No two couple’s fertility issues are the same, so a thorough assessment is required to determine the most effective form of treatment to fit their circumstances.

Overall, the new research into Kisspeptin IVF treatment has provided hope for those who may need IVF treatment in the future. However, for now patients have numerous fertility treatment options which could prove effective. Book an assessment today to start your fertility journey.